SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bioterrorism
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche3/25/2005 11:48:11 AM
   of 891
 
Date: Fri, 25 Mar 2005 11:06:19 -0500
From: "Sullivan, Nancy (NIH/VRC)"
Subject: VRC Seminars - 3/29/05 - Dr. Tom Monath
To: VRCSEMINAR@LIST.NIH.GOV


Tuesday's seminar will be presented by Dr. Tom Monath, of Acambis, Inc., entitled " Novel live attenuated vaccines utilizing yellow fever 17D as a vector"



This seminar will begin promptly at 4, and will be held in Building 40 in the main conference room (room 1201).



For more information on the VRC Seminar series (including a full schedule), see <http://vrc.nih.gov/cgi-shl/vrc/seminars.cfm>.

(just posting as it has a biotech connection and because there's a link to sign up for seminar notices, in the event that anyone is interested)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News